REXAHN PHARMACEUTICALS, INC. 10-Q 9-30-2015

Company

Opus Genetics, Inc.

Filed

November 2, 2015

Period of Report

September 30, 2015

Accession Number

0001140361-15-039272

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →